How to buy AFT Pharmaceuticals shares

AFT Pharmaceuticals Limited is a drug manufacturers—specialty & generic business based in Australia. AFT Pharmaceuticals shares (AFP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. and has a market cap (total outstanding shares value) of $479.3 million.

How to buy shares in AFT Pharmaceuticals

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for AFT Pharmaceuticals. Find the share by name or ticker symbol: AFP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AFT Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $4.71, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of AFT Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

US stocks

eToro Share Trading (US stocks)

Finder Award

Our top pick for

Cheap broker fees

IG Share Trading

Finder Award

Our top pick for

Long-term investing

CMC Markets Stockbroking

Finder Award

How has coronavirus impacted AFT Pharmaceuticals's share price?

Since the stock market crash in March caused by coronavirus, AFT Pharmaceuticals's share price has had significant positive movement.

Its last market close was $4.71, which is 34.18% up on its pre-crash value of $3.1 and 51.94% up on the lowest point reached during the March crash when the shares fell as low as $3.1.

If you had bought $1,000 worth of AFT Pharmaceuticals shares at the start of February 2020, those shares would have been worth $1,129.03 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,519.35.

AFT Pharmaceuticals share price

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

Sort by:

Name	Product	Standard brokerage fee	Inactivity fee	Markets
IG Share Trading Finder Award		AUD 8 or 0.1%	AUD 50 per quarter if you make fewer than three trades in that period	ASX shares, Global shares, Forex, CFDs, Margin trading	$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares. Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.	Go to site More Info	Compare	loading Fetching your data...
Bell Direct Share Trading Finder Award		AUD 15 or 0.1%	No	ASX shares, mFunds	Invest in Australian shares, options and managed funds from the one account with no inactivity fee. Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.	Go to site More Info	Compare	loading Fetching your data...
Superhero share trading		AUD 5	No	ASX shares	Pay zero brokerage on all Australian ETFs. Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.	Go to site More Info	Compare	loading Fetching your data...
CMC Markets Stockbroking Finder Award		AUD 11 or 0.1%	No	ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, mFunds	$0 brokerage on global shares including US, UK and Japan markets. Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.	Go to site More Info	Compare	loading Fetching your data...
ANZ Share Investing		AUD 19.95	No	ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants	Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments. Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.	More Info	Compare	loading Fetching your data...
Westpac Online Investing Account		AUD 19.95 or 0.11%	AUD 63.50 per year on the global markets account	ASX shares, Global shares, Options trading, US shares	More Info	Compare	loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

Is it a good time to buy AFT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is AFT Pharmaceuticals under- or over-valued?

Valuing AFT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AFT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AFT Pharmaceuticals's P/E ratio

AFT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, AFT Pharmaceuticals shares trade at around 39x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

AFT Pharmaceuticals share dividends

We're not expecting AFT Pharmaceuticals to pay a dividend over the next 12 months.

AFT Pharmaceuticals share price volatility

Over the last 12 months, AFT Pharmaceuticals's shares have ranged in value from as little as $2.66 up to $5.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AFT Pharmaceuticals's is 0.4146. This would suggest that AFT Pharmaceuticals's shares are less volatile than average (for this exchange).

AFT Pharmaceuticals overview

AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.

Frequently asked questions

• What percentage of AFT Pharmaceuticals is owned by insiders or institutions?

  Currently 76.093% of AFT Pharmaceuticals shares are held by insiders and 13.363% by institutions.

• When does the fiscal year end for AFT Pharmaceuticals?

  AFT Pharmaceuticals's fiscal year ends in March.

• Where is AFT Pharmaceuticals based?

  AFT Pharmaceuticals's address is: 129 Hurstmere Road, Auckland, New Zealand, 0622